Video games are a massive industry, and they’re successful because they have mastered the art of player engagement. What if you could apply those same tactics to engage doctors?

Sam Glassenberg, EVP at Relevate Health Games, formerly Level Ex, helps design video games for medical professionals and, more recently, patients. The goal is to equip them with new knowledge and skills to improve care delivery or build healthier habits.

Senior Writer Anastassia Gliadkovskaya sits down with Glassenberg to discuss the company’s latest innovations, engagement data and the future of video games in healthcare.

To learn more about the topics in this episode: 
Level Ex study shows efficacy of game-based training for experienced dermatologists 

Video games are a massive industry, and they&rsquo;re successful because they have mastered the art of player engagement. What if you could apply those same tactics to engage doctors?
Sam Glassenberg, EVP at Relevate Health Games, formerly Level Ex, helps design video games for medical professionals and, more recently, patients. The goal is to equip them with new knowledge and skills to improve care delivery or build healthier habits.
Senior Writer Anastassia Gliadkovskaya sits down with Glassenberg to discuss the company&rsquo;s latest innovations, engagement data and the future of video games in healthcare.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/health-tech/level-ex-study-shows-efficacy-game-based-training-experienced-dermatologists" aria-label="Link Level Ex study shows efficacy of game-based training for experienced dermatologists">Level Ex study shows efficacy of game-based training for experienced dermatologists</a>&nbsp;</li>
</ul>

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

How video games are changing medical education

The 2026 Fierce 50 brings together scientists, physicians, public health leaders, patient advocates and organizations working in very different ways to move healthcare and the life sciences forward. This year’s honorees are developing new medicines, closing gaps in access and representation, tackling health literacy and misinformation, rethinking disease prevention and finding new ways to bring public health information into the communities that need it.

In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison looks at some of the stories that stood out from this year’s honorees, from Revolution Medicines’ bet on the once “undruggable” RAS cancer target and the protein-design work of David Baker, Ph.D., to Michael Osterholm, Ph.D., and his decision to delay stepping back from public health. The episode also explores how honorees including Lisa Fitzpatrick, M.D., Hip Hop Public Health, Eric Topol, M.D., and Mary Owen, M.D., are rethinking trust, communication, prevention and health equity.

To learn more about the topics in this episode: 
Fierce 50 of 2026

The <a href="https://www.fiercepharma.com/collection/fierce-50-2026">2026 Fierce 50</a> brings together scientists, physicians, public health leaders, patient advocates and organizations working in very different ways to move healthcare and the life sciences forward. This year&rsquo;s honorees are developing new medicines, closing gaps in access and representation, tackling health literacy and misinformation, rethinking disease prevention and finding new ways to bring public health information into the communities that need it.
In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison looks at some of the stories that stood out from this year&rsquo;s honorees, from Revolution Medicines&rsquo; bet on the once &ldquo;undruggable&rdquo; RAS cancer target and the protein-design work of David Baker, Ph.D., to Michael Osterholm, Ph.D., and his decision to delay stepping back from public health. The episode also explores how honorees including Lisa Fitzpatrick, M.D., Hip Hop Public Health, Eric Topol, M.D., and Mary Owen, M.D., are rethinking trust, communication, prevention and health equity.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercepharma.com/collection/fierce-50-2026">Fierce 50 of 2026</a></li>
</ul>

The stories behind the 2026 Fierce 50

The U.S. is facing a rapidly aging population alongside a dearth of primary care physicians, who play a crucial role in catching health issues early and keeping costs low. Everyone agrees technology should play a role in filling care gaps, but where its value truly lies is up for debate.

Senior Writer Anastassia Gliadkovskaya talks to David Carmouche, M.D., chief medical and commercial officer of Lumeris, a health tech company that supports providers. Carmouche shares creative ways providers can use technology more effectively and the payment models needed to support those efforts long term. He also discusses lessons learned from leading Walmart Health centers, which shuttered in 2024, and his current work on a federal healthcare advisory committee to the Department of Health and Human Services.

To learn more about the topics in this episode: 
Walmart Health's shutdown underscores major challenges for retail health 'disruptors'
Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI t… 
Primary care is in trouble. So doctors band together to boost their market power 

The U.S. is facing a rapidly aging population alongside a <a href="https://www.fiercehealthcare.com/providers/primary-care-trouble-so-doctors-band-together-boost-their-market-power" data-start="136" data-end="259">dearth</a> of primary care physicians, who play a crucial role in catching health issues early and keeping costs low. Everyone agrees technology should play a role in filling care gaps, but where its value truly lies is up for debate.
Senior Writer Anastassia Gliadkovskaya talks to David Carmouche, M.D., chief medical and commercial officer of Lumeris, a health tech company that supports providers. Carmouche shares creative ways providers can use technology more effectively and the payment models needed to support those efforts long term. He also discusses lessons learned from leading Walmart Health centers, which shuttered in 2024, and his current work on a federal healthcare advisory committee to the Department of Health and Human Services.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/walmart-shuttering-all-51-health-centers-virtual-care" aria-label="Link Walmart Health's shutdown underscores major challenges for retail health 'disruptors'">Walmart Health's shutdown underscores major challenges for retail health 'disruptors'</a></li>
<li><a href="https://www.fiercehealthcare.com/health-tech/weekly-rundown-lumeris-adds-symptom-checking-tool-ai-platform-whoop-healthex-partner" aria-label="Link Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI t&hellip;">Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI t&hellip;</a>&nbsp;</li>
<li><a href="https://www.fiercehealthcare.com/providers/primary-care-trouble-so-doctors-band-together-boost-their-market-power" aria-label="Link Primary care is in trouble. So doctors band together to boost their market power">Primary care is in trouble. So doctors band together to boost their market power</a>&nbsp;</li>
</ul>

Primary care’s AI opportunity depends on new payment models

This podcast episode is sponsored by Johnson & Johnson and Legend Biotech. Dr. Paresh Patel and multiple myeloma patient Julia P. have been compensated by Johnson & Johnson and Legend Biotech for their time to participate in this podcast.

In this episode of Podnosis: The Pulse of the Healthcare Industry, listeners hear a candid conversation about multiple myeloma from the patient and physician perspectives. A patient who underwent CAR-T therapy and her community oncologist, Dr. Paresh Patel, share how early education, trust and collaboration shaped her treatment journey.

The patient walks through her experience from diagnosis to CAR-T, describing how informed decision-making and self-advocacy helped her navigate an evolving treatment landscape. She reflects on the emotional and practical challenges of multiple myeloma therapies, the importance of caregiver support and what the possibility of a treatment-free interval meant to her.

Dr. Patel discusses the role of community oncologists in managing complex diseases like multiple myeloma, emphasizing why CAR-T should remain part of the treatment conversation early on. He explores timing, referral considerations and the value of clear communication as patients move between local care and specialized centers. At its core, this episode is about partnership and what is possible when patients and care teams navigate complexity together.

This podcast episode is sponsored by Johnson &amp; Johnson and Legend Biotech. Dr. Paresh Patel and multiple myeloma patient Julia P. have been compensated by Johnson &amp; Johnson and Legend Biotech for their time to participate in this podcast.
In this episode of Podnosis: The Pulse of the Healthcare Industry, listeners hear a candid conversation about multiple myeloma from the patient and physician perspectives. A patient who underwent CAR-T therapy and her community oncologist, Dr. Paresh Patel, share how early education, trust and collaboration shaped her treatment journey.
The patient walks through her experience from diagnosis to CAR-T, describing how informed decision-making and self-advocacy helped her navigate an evolving treatment landscape. She reflects on the emotional and practical challenges of multiple myeloma therapies, the importance of caregiver support and what the possibility of a treatment-free interval meant to her.
Dr. Patel discusses the role of community oncologists in managing complex diseases like multiple myeloma, emphasizing why CAR-T should remain part of the treatment conversation early on. He explores timing, referral considerations and the value of clear communication as patients move between local care and specialized centers. At its core, this episode is about partnership and what is possible when patients and care teams navigate complexity together.

How video games are changing medical education

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips